Concepedia

Publication | Closed Access

Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma

DOI

187

Citations

33

References

2021

Year

Joyce F. Liu, Niya Xiong, Susana M. Campos, Alexi A. Wright, Carolyn Krasner, Susan Schumer, Neil S. Horowitz, Jennifer Veneris, Nabihah Tayob, Stephanie Morrissey,
Journal of Clinical Oncology

Abstract

Adavosertib monotherapy demonstrated encouraging and durable evidence of activity in women with USC, and further investigation of this agent in this cancer and biomarkers of activity are indicated.

References

YearCitations

Page 1